ROYAL BANK OF CANADA - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,000
+100.0%
1,699
-10.5%
0.00%
Q1 2023$1,000
-50.0%
1,899
-24.7%
0.00%
Q4 2022$2,000
-33.3%
2,521
-1.2%
0.00%
Q3 2022$3,0002,551
+433.7%
0.00%
Q2 2022$0
-100.0%
478
-92.1%
0.00%
Q1 2022$5,000
-86.1%
6,036
-73.3%
0.00%
Q4 2021$36,000
+24.1%
22,601
+89.9%
0.00%
Q3 2021$29,000
+107.1%
11,903
+128.2%
0.00%
Q2 2021$14,000
-56.2%
5,217
-17.8%
0.00%
Q1 2021$32,0006,345
+634400.0%
0.00%
Q3 2020$01
-99.8%
0.00%
Q2 2020$04490.0%0.00%
Q1 2020$0449
-1.5%
0.00%
Q3 2019$04560.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GENDELL JEFFREY L 4,933,024$4,133,0000.30%
ACUTA CAPITAL PARTNERS, LLC 295,896$248,0000.12%
Connacht Asset Management LP 231,551$194,0000.10%
Uniplan Investment Counsel, Inc. 1,564,605$1,310,0000.08%
AdvisorShares Investments LLC 358,796$301,0000.05%
1492 Capital Management LLC 99,819$84,0000.04%
Woodline Partners LP 2,803,230$2,349,0000.04%
Ikarian Capital, LLC 257,883$215,0000.03%
Sovereign Financial Group, Inc. 75,000$63,0000.02%
Aquatic Capital Management LLC 6,400$5,0000.01%
View complete list of SEELOS THERAPEUTICS INC shareholders